Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2619 USD | +0.70% | -13.56% | -37.04% |
Business Summary
Number of employees: 13
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
BayMedica
100.0
%
| 1 | 100.0 % | 4 | 100.0 % | +279.61% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 4 | 100.0 % | +279.61% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16/16/16 |
Chief Operating Officer | - | 05/18/05 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Gerard Griffin
SAM | Sales & Marketing | - | 01/22/01 |
Eric Hsu
PRN | Corporate Officer/Principal | - | 13/18/13 |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 11/22/11 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16/16/16 |
Andrew Hull
CHM | Chairman | 61 | 12/16/12 |
Bryan Baldasare
BRD | Director/Board Member | 58 | 12/22/12 |
Nicole Lemerond
BRD | Director/Board Member | 49 | 08/22/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,056,970 | 5,974,441 ( 98.64 %) | 0 | 98.64 % |
Company contact information
InMed Pharmaceuticals, Inc.
815 West Hastings Street Suite 310
V6C 1B4, Vancouver
+604 669 7207
http://www.inmedpharma.comSector
Sales per Business
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.04% | 1.59M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+2.13% | 22.25B | |
-14.77% | 21.68B | |
-8.79% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- INM Stock
- Company InMed Pharmaceuticals Inc.